Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,514 | 75,561 | 46,656 | 24,840 | 54,116 |
| Marketable Securities | 226,696 | 244,200 | 114,122 | 64,714 | 60,025 |
| Receivables | 38,148 | 8,587 | 473 | 1,032 | 2,136 |
| Other current assets | 4,199 | 3,831 | 1,412 | 1,010 | 851 |
| TOTAL | $345,032 | $337,913 | $167,997 | $93,371 | $118,148 |
| Non-Current Assets | |||||
| PPE Net | 28,973 | 28,702 | 13,977 | 9,324 | 538 |
| Investments And Advances | 103,785 | 150,819 | 15,616 | 69,412 | 102,526 |
| Other Non-Current Assets | 20,118 | 26,380 | 1,087 | 625 | 168 |
| TOTAL | $152,876 | $205,901 | $30,680 | $79,361 | $103,232 |
| Total Assets | $497,908 | $543,814 | $198,677 | $172,732 | $221,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,409 | 4,412 | 4,832 | 1,543 | 1,014 |
| Accrued Expenses | 24,846 | 17,164 | 9,605 | 8,126 | 3,198 |
| Other current liabilities | N/A | N/A | N/A | N/A | 127 |
| TOTAL | $33,676 | $22,176 | $14,437 | $9,669 | $4,339 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 600 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 10,702 | 2,505 | 0 | 0 | 0 |
| TOTAL | $14,035 | $12,790 | $1,211 | $1,326 | $233 |
| Total Liabilities | $47,711 | $34,966 | $15,648 | $10,995 | $4,572 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,139 | 36,419 | 31,655 | 26,513 | 26,329 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -177,822 | -83,016 | -187,756 | -114,587 | -51,620 |
| Other shareholders' equity | 205 | -720 | -715 | -33 | -719 |
| TOTAL | $450,197 | $508,848 | $183,029 | $161,737 | $216,808 |
| Total Liabilities And Equity | $497,908 | $543,814 | $198,677 | $172,732 | $221,380 |